Article Information.
Acknowledgements: The skilled and dedicated assistance of the
following individuals for the clinical components of the study is
acknowledged, none of whom were compensated for their contributions:
Spartanburg Regional Hospital, Spartanburg, SC: Jill Cole; University of
Melbourne, Australia: Christine Knight, Dr Jennifer Conn, Susan Hiscock,
Dr Jeremy Oats, Peter Wein; University of Oklahoma, Oklahoma City, OK:
Azar Dashti.
Declaration of interests: The authors have declared that no
conflicts of interest exist.
Ethics approval: The study was approved by the Institutional
Review Boards of all the participating institutions and by the Ethics
Committee of the Medical University of South Carolina (IRB#: 81076,
Date: Aug 14, 2018); it was conducted according to the principles of the
Declaration of Helsinki.
Data Availability: The data that support the findings of this
study are available from the corresponding author on reasonable request.
Funding/Sponsor: This work was supported by Research Grants
from the Juvenile Diabetes Research Foundation (JDRF 1-2001-844), and
Novo Nordisk to TJL, and by NIH (NCRR) Grants M01-RR-1070 and M01
RR-14467 to the General Clinical Research Centers at MUSC and OUHSC
respectively. Support from Novo Nordisk enabled the participation of the
Barbara Davis Diabetes Center for Childhood Diabetes at the University
of Colorado.
Role of the Funder/Sponsor: The sponsors had no role in the
design and conduct of the study; collection, management, analysis, and
interpretation of the data; preparation, review, or approval of the
manuscript; and decision to submit the manuscript for publication.